Filing Details

Accession Number:
0001140361-14-002169
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-01-14 18:11:01
Reporting Period:
2014-01-10
Filing Date:
2014-01-14
Accepted Time:
2014-01-14 18:11:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1095981 Cytori Therapeutics Inc. CYTX Surgical & Medical Instruments & Apparatus (3841) 330827593
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168215 J Christopher Calhoun 3020 Callan Road
San Diego CA 92121
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-01-10 500 $2.81 146,770 No 4 S Direct
Common Stock Disposition 2014-01-10 2,600 $2.82 144,170 No 4 S Direct
Common Stock Disposition 2014-01-10 1,200 $2.83 142,970 No 4 S Direct
Common Stock Disposition 2014-01-10 700 $2.84 142,270 No 4 S Direct
Common Stock Disposition 2014-01-10 600 $600.00 141,670 No 4 S Direct
Common Stock Disposition 2014-01-10 1,200 $2.86 140,470 No 4 S Direct
Common Stock Disposition 2014-01-10 900 $2.87 139,570 No 4 S Direct
Common Stock Disposition 2014-01-10 2,300 $2.88 137,270 No 4 S Direct
Common Stock Disposition 2014-01-10 3,399 $2.89 133,871 No 4 S Direct
Common Stock Disposition 2014-01-10 400 $2.90 133,471 No 4 S Direct
Common Stock Disposition 2014-01-10 2,100 $2.92 131,371 No 4 S Direct
Common Stock Disposition 2014-01-10 5,803 $2.93 125,568 No 4 S Direct
Common Stock Disposition 2014-01-10 4,043 $2.94 121,525 No 4 S Direct
Common Stock Disposition 2014-01-10 1,400 $2.95 120,125 No 4 S Direct
Common Stock Disposition 2014-01-10 2,000 $2.96 118,125 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 36,850 Indirect By 401(k) Plan
Footnotes
  1. Shares sold pursuant to a 10b5-1 Plan.